NOTE 13 – SUBSEQUENT EVENTS

On July 20, 2026, the Compensation Committee approved (i) an amendment to a previously granted stock option award, modifying the vesting schedule from quarterly vesting to monthly vesting effective July 1, 2026, and (ii) the grant of stock options to purchase 50,000 shares of the Company’s common stock under the Company’s 2025 Stock Plan. The options vest 50% on the first anniversary of the employee’s start date and 50% on the second anniversary of the employee’s start date, subject to continued employment, have a 5 five-year contractual term, and an exercise price equal to the fair market value of the Company’s common stock on the grant date.

On August 6, 2026, the Compensation Committee approved the grant of stock options to purchase 30,000 shares of the Company’s common stock under the Company’s 2025 Stock Plan to an employee. The options vest 50% on the grant date and 50% on the first anniversary of the grant date, subject to continued service, have a five-year contractual term, and an exercise price equal to the fair market value of the Company’s common stock on the grant date.

All equity awards granted subsequent to June 30, 2026 were approved by the Company’s Compensation Committee, were measured at fair value as of the applicable grant dates based on the closing price of the Company’s common stock and are subject to the terms and conditions of the Company’s equity incentive plans and applicable award agreements.